Viewing Study NCT03468335


Ignite Creation Date: 2025-12-24 @ 10:22 PM
Ignite Modification Date: 2025-12-25 @ 7:54 PM
Study NCT ID: NCT03468335
Status: COMPLETED
Last Update Posted: 2025-04-17
First Post: 2018-01-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: 2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line Therapy
Sponsor: AIO-Studien-gGmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module